Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/31/2013 | WO2003023014A9 Human ion channels |
10/31/2013 | WO2003020910A9 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8 |
10/31/2013 | WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis |
10/31/2013 | WO2002094993A9 Kin28 polynucleotides and polypeptides and uses thereof |
10/31/2013 | WO2002078598A3 Peptides and antibodies to muc 1 proteins |
10/31/2013 | WO2002077260A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
10/31/2013 | WO2002077001A9 Novel receptors |
10/31/2013 | WO2002074973A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
10/31/2013 | WO2002069885A9 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases |
10/31/2013 | WO2002059349A9 Odorant receptors and uses thereof |
10/31/2013 | US20130291234 Salt tolerance sydbsp gene derived from synechocystis, and uses thereof |
10/31/2013 | US20130291220 Genes Involved in Tolerance to Environmental Stress |
10/31/2013 | US20130291202 Plants and seeds of corn variety cv568858 |
10/31/2013 | US20130291160 Plants and seeds of hybrid corn variety ch175075 |
10/31/2013 | US20130289261 Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen |
10/31/2013 | US20130289253 Reversible protein multimers, methods for their production and use |
10/31/2013 | US20130289252 Compositions and methods for the delivery of nitric oxide |
10/31/2013 | US20130289243 Collagen producing plants and methods of generating and using same |
10/31/2013 | US20130289242 Method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof |
10/31/2013 | US20130288983 Variant activin receptor polypeptides and uses thereof |
10/31/2013 | US20130288980 Targeting senescent and cancer cells for selective killing by interference with foxo4 |
10/31/2013 | US20130288974 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
10/31/2013 | US20130288971 Short peptides for enhancing muscle function |
10/31/2013 | US20130288970 Compositions and methods for the delivery of oxygen |
10/31/2013 | US20130288965 Use of peptides for promoting wound healing |
10/31/2013 | US20130288963 Anticancer fusion protein |
10/31/2013 | US20130288960 Double-Acylated GLP-1 Derivatives |
10/31/2013 | US20130288959 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor |
10/31/2013 | US20130288958 Novel Glucagon Analogues |
10/31/2013 | US20130288949 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
10/31/2013 | US20130288948 Establishment of motif comprising acidic amino acid, capable of stabilizing protein in cells, and applicable to protein therapy, control of differentiation/undifferentiation of cell and antibody therapy |
10/31/2013 | US20130288376 System for and method of separating germ from grains used for alcohol production |
10/31/2013 | US20130288372 Fibronectin based scaffold domain proteins that bind il-23 |
10/31/2013 | US20130288364 Engineered kinetochores and uses thereof |
10/31/2013 | US20130288333 Protein complex using an immunoglobulin fragment and method for the preparation thereof |
10/31/2013 | US20130288300 Polypeptides Having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same |
10/31/2013 | US20130287839 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
10/31/2013 | US20130287816 P97 protein and uses thereof as vaccine adjuvant |
10/31/2013 | US20130287813 Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use |
10/31/2013 | US20130287806 Immune-modulating agents and uses therefor |
10/31/2013 | US20130287804 Immunogenic polypeptides having an immunogenic scaffold protein and a loop peptide, presenting a 3074- or 2219/2557- monoclonal antibody-targeted epitope, which is present in the hiv gp120 protein |
10/31/2013 | US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
10/31/2013 | US20130287784 Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy |
10/31/2013 | US20130287782 Enterococcus antigens |
10/31/2013 | US20130287746 Radiation cross-linked collagen gel, and preparation method and usage method thereof |
10/31/2013 | US20130287738 Disease-associated protein |
10/31/2013 | US20130287733 Interferon alpha mutant and its polyethylene glycol derivative |
10/31/2013 | US20130287693 NOGO Receptor Binding Protein |
10/30/2013 | EP2657703A1 Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria |
10/30/2013 | EP2657341A2 Plants having enhanced yield-related traits and a method for making the same |
10/30/2013 | EP2657340A1 Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy |
10/30/2013 | EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof |
10/30/2013 | EP2657252A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same |
10/30/2013 | EP2657251A1 Live, oral vaccine for protection against Shigella dysenteriae serotype 1 |
10/30/2013 | EP2657250A2 Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same |
10/30/2013 | EP2657249A2 Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same |
10/30/2013 | EP2657248A1 AAV virions with decreased immunoreactivity and uses therefor |
10/30/2013 | EP2657247A1 AAV virions with decreased immunoreactivity and uses therefor |
10/30/2013 | EP2656859A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
10/30/2013 | EP2655637A1 Thermostable c. bescii enzymes |
10/30/2013 | EP2655633A1 Disruption of ahp6 gene leads to plants with improved seed yield |
10/30/2013 | EP2655630A1 Method for producing apolipoprotein in plants |
10/30/2013 | EP2655613A1 Virus like particle production in plants |
10/30/2013 | EP2655607A2 Methods and compositions for producing active vitamin k-dependent proteins |
10/30/2013 | EP2655411A1 Fibronectin based scaffold domain proteins that bind il-23 |
10/30/2013 | EP2655410A2 Anti-inflammatory proteins and methods of preparation and use thereof |
10/30/2013 | EP2655409A1 Superagonists and antagonists of interleukin-2 |
10/30/2013 | EP2655408A1 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma |
10/30/2013 | EP2655407A2 Tnf family ligand variants |
10/30/2013 | EP2655406A1 Plant gene expression modulatory sequences from maize |
10/30/2013 | EP2655405A2 Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides |
10/30/2013 | EP2655404A1 Novel alkali-resistant variants of protein a and their use in affinity chromatography |
10/30/2013 | EP2655403A1 Vaccines with live bacterial isolates for systemic administration |
10/30/2013 | EP2655402A1 Oprf/i agents and their use in hospitalized and other patients |
10/30/2013 | EP2655401A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
10/30/2013 | EP2655397A1 Method for extracting human serum albumin from transgenic rice grain |
10/30/2013 | EP2655396A1 Method for purifying human serum albumin from transgenic rice grain |
10/30/2013 | EP2655395A2 Method for cross-linking peptides |
10/30/2013 | EP2654915A1 Affinity chromatography matrix |
10/30/2013 | EP2654914A1 Affinity chromatography matrix |
10/30/2013 | EP2654804A1 Her2 binding peptides labeled with aluminium-[18]fluoride complexed by nota |
10/30/2013 | EP2654803A1 Radiolabled her2 binding peptides |
10/30/2013 | EP2654786A1 Adenoviral vector-based dengue fever vaccine |
10/30/2013 | EP2654772A2 Cyclic crf antagonist peptides |
10/30/2013 | CN1922199B CA6 antigen-specific cytotoxic conjugate and methods of using same |
10/30/2013 | CN103380146A Lipidated polyepitope vaccines |
10/30/2013 | CN103380143A Fibronectin based scaffold domain proteins that bind IL-23 |
10/30/2013 | CN103379909A Novel bacterium and extracts of said bacterium and the use of same in therapy |
10/30/2013 | CN103376322A Application of apolipoprotein B 100 as marker of obesity-diabetes |
10/30/2013 | CN103374628A Congenital heart defect (CHD)-related gene family with sequence similarity 71, member A (FAM71A) and application thereof |
10/30/2013 | CN103374627A Congenital heart defect (CHD)-related gene polycystic kidney disease 1 like l (PKD1L1) and application thereof |
10/30/2013 | CN103374625A Congenital heart disease related gene DLC1 and application thereof |
10/30/2013 | CN103374588A Production method of recombinant human blood coagulation factor XIIa |
10/30/2013 | CN103374580A Enterovirus 71 (EV 71) Fuyang strain and cDNA (deoxyribonucleic acid) infectious clone of attenuated strain of enterovirus 71 (EV 71) Fuyang strain as well as application of enterovirus 71 (EV 71) Fuyang strain |
10/30/2013 | CN103374578A Gene G13 for regulating length and weight of rice grains and application |
10/30/2013 | CN103374577A Sheep ISG (immune serum globulin) 15 recombinant protein as well as coding gene and application thereof |
10/30/2013 | CN103374576A Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
10/30/2013 | CN103374575A CYP4V2 gene mutant and application thereof |
10/30/2013 | CN103374574A CYP4V2 gene mutant and application thereof |
10/30/2013 | CN103374567A Schistosoma japonicum calcium-binding EF-hand domain containing protein (SjEFCAB) recombinant antigen protein and preparation method and application thereof |